Paper36943247
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group.
Wagner E and 11 others. Schizophr Bull, 2023. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group. Papers, record 36943247. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36943247
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clozapine | Major topic |
| Psychotic Disorders | Major topic |
| Humans | |
| Consensus | |
| Delphi Technique |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22834451 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. | World J Biol Psychiatry | 2012 | https://conductscience.org/library/papers/22834451 | PubMed |
| 2 | 34588212 | Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology. | Evid Based Ment Health | 2022 | https://conductscience.org/library/papers/34588212 | PubMed |
| 3 | 28747065 | Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations. | Aust N Z J Psychiatry | 2017 | https://conductscience.org/library/papers/28747065 | PubMed |
| 4 | 35086595 | Treatment strategies for clozapine-induced nocturnal enuresis and urinary incontinence: a systematic review. | CNS Spectr | 2022 | https://conductscience.org/library/papers/35086595 | PubMed |
| 5 | 27716110 | Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. | BMC Psychiatry | 2016 | https://conductscience.org/library/papers/27716110 | PubMed |
| 6 | 35164895 | Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017. | Br J Psychiatry | 2022 | https://conductscience.org/library/papers/35164895 | PubMed |
| 7 | 35210430 | Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics. | Schizophrenia (Heidelb) | 2022 | https://conductscience.org/library/papers/35210430 | PubMed |
| 8 | 31365048 | Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies. | JAMA Psychiatry | 2019 | https://conductscience.org/library/papers/31365048 | PubMed |
| 9 | 29455687 | Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia. | Psychol Med | 2018 | https://conductscience.org/library/papers/29455687 | PubMed |
| 10 | 31205196 | Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review. | J Clin Psychopharmacol | 2019 | https://conductscience.org/library/papers/31205196 | PubMed |
| 11 | 22831769 | Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? | Schizophr Res | 2012 | https://conductscience.org/library/papers/22831769 | PubMed |
| 12 | 33543755 | There Is Life After the UK Clozapine Central Non-Rechallenge Database. | Schizophr Bull | 2021 | https://conductscience.org/library/papers/33543755 | PubMed |
| 13 | 34911124 | An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels. | Pharmacopsychiatry | 2022 | https://conductscience.org/library/papers/34911124 | PubMed |
| 14 | 30758782 | Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis. | CNS Drugs | 2019 | https://conductscience.org/library/papers/30758782 | PubMed |
| 15 | 31766049 | Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis. | Neuropsychopharmacology | 2020 | https://conductscience.org/library/papers/31766049 | PubMed |
| 16 | 34552059 | Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/34552059 | PubMed |
| 17 | 34374073 | Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis. | Acta Psychiatr Scand | 2021 | https://conductscience.org/library/papers/34374073 | PubMed |
| 18 | 31922665 | Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics. | World Psychiatry | 2020 | https://conductscience.org/library/papers/31922665 | PubMed |
| 19 | 34715441 | Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review. | Psychiatry Res | 2021 | https://conductscience.org/library/papers/34715441 | PubMed |
| 20 | 22113154 | When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. | Schizophr Res | 2012 | https://conductscience.org/library/papers/22113154 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42951688 | Clozapine Augmentation Strategies and Clinical Predictors of Prolonged Tertiary Hospitalization in Clozapine-Resistant Schizophrenia: a Retrospective Cohort Study. | Schizophr Bull | 2026 | https://conductscience.org/library/papers/42951688 | PubMed |
| 42882089 | Clinical Outcomes and Treatment Characteristics of Seizure Threshold-Titrated Electroconvulsive Therapy in Schizophrenia: A 3.5-Year Retrospective Naturalistic Course-Level Study. | J Clin Med | 2026 | https://conductscience.org/library/papers/42882089 | PubMed |
| 42668991 | Physical Therapies and Neuromodulation for Treatment-Resistant Schizophrenia: A Review of Potential Mechanisms, Efficacy, and Safety. | Neuropsychiatr Dis Treat | 2026 | https://conductscience.org/library/papers/42668991 | PubMed |
| 42136416 | Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages. | World Psychiatry | 2026 | https://conductscience.org/library/papers/42136416 | PubMed |
| 41613742 | A Call to Action for Starting Clozapine: Increasing Clozapine Use and Safety in a Post-REMS Era. | Focus (Am Psychiatr Publ) | 2025 | https://conductscience.org/library/papers/41613742 | PubMed |
| 40843609 | Clozapine Dose Reduction in Remitted Patients With Treatment-Resistant Schizophrenia: A Case Series. | Schizophr Bull | 2026 | https://conductscience.org/library/papers/40843609 | PubMed |
| 40445982 | Violence victimization and perpetration within the caregiver-patient relationship in schizophrenia: A cross-sectional study in Tunisia. | PLoS One | 2025 | https://conductscience.org/library/papers/40445982 | PubMed |
| 40371869 | Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts. | World Psychiatry | 2025 | https://conductscience.org/library/papers/40371869 | PubMed |
| 40198784 | Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes. | J Clin Psychopharmacol | 2025 | https://conductscience.org/library/papers/40198784 | PubMed |
| 40121574 | Clozapine-Related Tachycardia: An Analysis of Incidence. | CNS Drugs | 2025 | https://conductscience.org/library/papers/40121574 | PubMed |
| 40070369 | A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis. | Neuropsychiatr Dis Treat | 2025 | https://conductscience.org/library/papers/40070369 | PubMed |
| 39598541 | Manipulation of Lipid Nanocapsules as an Efficient Intranasal Platform for Brain Deposition of Clozapine as an Antipsychotic Drug. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39598541 | PubMed |
| 39359152 | Understanding the medication regimens associated with anticholinergic burden in older people's mental health services in the UK. | BJPsych Open | 2024 | https://conductscience.org/library/papers/39359152 | PubMed |
| 39199294 | What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199294 | PubMed |
| 38951464 | When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis. | CNS Drugs | 2024 | https://conductscience.org/library/papers/38951464 | PubMed |
| 38713070 | Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study. | Schizophr Bull | 2025 | https://conductscience.org/library/papers/38713070 | PubMed |
| 38236524 | Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review. | CNS Drugs | 2024 | https://conductscience.org/library/papers/38236524 | PubMed |
| 38165458 | Vaccination and clozapine use: a systematic review and an analysis of the VAERS database. | Eur Arch Psychiatry Clin Neurosci | 2025 | https://conductscience.org/library/papers/38165458 | PubMed |
| 37489558 | CONSENSUS BY THE COLLECTIVE OF PSYCHIATRISTS FOR THE CLOZAPINE UPDATE. | Actas Esp Psiquiatr | 2023 | https://conductscience.org/library/papers/37489558 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36943247
GET https://conductscience.org/api/papers/v1/36943247/references?page=2